Skip to main content

Andlauer Healthcare Group Inc(AND-T)

Today's Change
Real-Time Last Update

Andlauer Healthcare Group Inc stock boosted on Tuesday.

The Globe and Mail - Tue Jun 21, 3:09PM CDT

Andlauer Healthcare Group Inc opened trading today at $39.49 and closed at $41.12. Intraday prices ranged from $39.49 to $41.56.

The price advanced 2.03% from the previous day's close of $40.30.

Today across North America, the TSX Composite closed 1.28% at 19173.08, the S&P 500 closed 0.22% at 3674.84, the Dow Jones Industrial Average closed -0.13% at 29888.78 and the Nasdaq Composite closed 1.43% at 10798.35.

Andlauer Healthcare Group Inc traded under AND.TO on the TSX stock exchange.

Trading volume was 12,332 on 87 total trades, with an average volume of 14,554 over 5 days.

Trading across the entire TSX saw 4,426 price advancers against 1,279 declines and 198 unchanged.

During the prior 52 weeks, AND.TO has traded as high as $55.84 (December 22,2021) and low as $35.26 (June 28,2021). Moreover, in the last 12 months, Andlauer Healthcare Group Inc's shares have boosted 15.39%, while in 2022, they have reduced -23.12%.

AND.TO's updated dividend yield is 0.21%. It announced a 0.06 dividend on June 15/22, with an June 29/22 ex-date and July 15/22 pay day.

Following today's trading, Andlauer Healthcare Group Inc has a market capitalization of $1.69 billion on a float of 41,824 shares outstanding. Its annual EPS is $2.34.

Andlauer Healthcare Group Inc is a TSX Integrated Shipping & Logis company headquartered in Vaughan, US.

Currently, Andlauer Healthcare Group Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 1 have buy ratings and 3 analysts gave hold ratings.

Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation that help readers identify investment opportunities across Canadian and US markets. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.